{"chunk_id": "medquad__chunk_50153", "source": "medquad", "text": "inject the EPO themselves. Patients on hemodialysis may receive EPO intravenously during hemodialysis.\n                \nStudies have shown the use of EPO increases the chance of cardiovascular events, such as heart attack and stroke, in people with CKD. The health care provider will carefully review the medical history of the patient and determine if EPO is the best treatment for the patients anemia. Experts recommend using the lowest dose of EPO that will reduce the need for red blood cell tra"}